Importantly, we further revealed the negative correlation of circulating sEV PD-1/CD80 levels with ICAM-1, MHC-I and TAP1 levels in patients with HNSCC (Supplementary Fig. 7b). This evidence concerns the gene ICAM1 and head and neck squamous cell carcinoma.